Rezultati pretrage - Matthew L. Sherman

  • Prikaz rezultata 1 – 19 od 19
Detaljiziraj rezultate
  1. 1
    Transcriptional and posttranscriptional regulation of macrophage-specific colony stimulating factor gene expression by tumor necrosis factor. Involvement of arachidonic acid metabolites.

    Transcriptional and posttranscriptional regulation of macrophage-specific colony stimulating factor gene expression by tumor necrosis factor. Involvement of arachidonic acid metabo... od Matthew L. Sherman, Barbara Weber, Rakesh Datta, Donald Küfe

    Izdano 1990
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Effect of tumor necrosis factor on GTP binding and GTPase activity in HL-60 and L929 cells.

    Effect of tumor necrosis factor on GTP binding and GTPase activity in HL-60 and L929 cells. od K. Imamura, Matthew L. Sherman, David R. Spriggs, Donald Küfe

    Izdano 1988
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells.

    Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. od Matthew L. Sherman, Richard M. Stone, Rakesh Datta, Steven H. Bernstein, Donald Küfe

    Izdano 1990
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes.

    Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. od Matthew L. Sherman, Rakesh Datta, Dennis E. Hallahan, R.R. Weichselbaum, Donald Küfe

    Izdano 1991
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Locally acting ACE‐083 increases muscle volume in healthy volunteers

    Locally acting ACE‐083 increases muscle volume in healthy volunteers od Chad Glasser, Michael Gartner, Dawn Wilson, Barry Miller, Matthew L. Sherman, Kenneth M. Attie

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Chronic TNF Infusion Causes Anorexia But Not Accelerated Nitrogen Loss

    Chronic TNF Infusion Causes Anorexia But Not Accelerated Nitrogen Loss od H. R. Michie, Matthew L. Sherman, David R. Spriggs, MARY CHRISTIE, Douglas W. Wilmore, Jan D. Rounds

    Izdano 1989
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    A phase 1 study of ACE‐536, a regulator of erythroid differentiation, in healthy volunteers

    A phase 1 study of ACE‐536, a regulator of erythroid differentiation, in healthy volunteers od Kenneth M. Attie, Mark Allison, Ty McClure, Ingrid E. Boyd, Dawn Wilson, Amelia E. Pearsall, Matthew L. Sherman

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Multiple‐dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA‐IgG1), a novel erythropoietic agent, in healthy postmenopausal women

    Multiple‐dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA‐IgG1), a novel erythropoietic agent, in healthy postmenopausal women od Matthew L. Sherman, Niels Borgstein, Louisa Mook, Dawn Wilson, Yijun Yang, Nianhang Chen, Ravindra Kumar, Kenneth Kim, Abderrahmane Laadem

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Sotatercept in patients with osteolytic lesions of multiple myeloma

    Sotatercept in patients with osteolytic lesions of multiple myeloma od Abdulkadyrov Km, Galina Salogub, Nuriet K. Khuazheva, Matthew L. Sherman, Abderrahmane Laadem, Rachel Barger, Robert Knight, Shankar Srinivasan, Evangelos Terpos

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies

    Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based... od H. Raftopoulos, Abderrahmane Laadem, Paul J. Hesketh, Jerome H. Goldschmidt, Nashat Gabrail, Cynthia R. Osborne, Muhammad Ali, Matthew L. Sherman, Ding Wang, John A. Glaspy, Marie Puccio-Pick, Jun Zou, Jeffrey Crawford

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

    Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma od Michael B. Atkins, Manuel Hidalgo, Walter M. Stadler, Theodore F. Logan, Janice P. Dutcher, Gary R. Hudes, Young Joo Park, Song-Heng Liou, Bonnie Marshall, Joseph Boni, Gary Dukart, Matthew L. Sherman

    Izdano 2004
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia

    Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia od Antonio Piga, Silverio Perrotta, Maria Rita Gamberini, Ersi Voskaridou, Angela Melpignano, Aldo Filosa, Vincenzo Caruso, Antonello Pietrangelo, Filomena Longo, Immacolata Tartaglione, Caterina Borgna‐Pignatti, Xiaosha Zhang, Abderrahmane Laadem, Matthew L. Sherman, Kenneth M. Attie

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease

    A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease od Robert Burakoff, Charles F. Barish, Dennis Riff, Ronald E. Pruitt, William Y. Chey, Francis A. Farraye, Ira Shafran, Seymour Katz, Charles L. Krone, Martha Vander Vliet, Christopher Stevens, Matthew L. Sherman, Eric Jacobson, Ronald Bleday

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer

    Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer od Johanna C. Bendell, Michael S. Gordon, Herbert I. Hurwitz, Suzanne F. Jones, David S. Mendelson, Gerard C. Blobe, Neeraj Agarwal, Carolyn H. Condon, Dawn Wilson, Amelia E. Pearsall, Yijun Yang, Ty McClure, Kenneth M. Attie, Matthew L. Sherman, Sunil Sharma

    Izdano 2013
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial

    Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial od Sebastian Bauer, Robin L. Jones, Jean‐Yves Blay, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Ying Su, Julie Meade, Tao Wang, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Michael C. Heinrich

    Izdano 2022
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    CSF1R Inhibition in Patients With Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase 1 Study of Vimseltinib

    CSF1R Inhibition in Patients With Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase 1 Study of Vimseltinib od Hans Gelderblom, Albiruni Abdul Razak, Matthew H. Taylor, Todd M. Bauer, Breelyn A. Wilky, Javier Martín‐Broto, Alejandro Falcón, Piotr Rutkowski, Bartłomiej Szostakowski, Thierry Alcindor, Ramy Saleh, Sofia Genta, Silvia Stacchiotti, Michiel A. J. van de Sande, Andrew J. Wagner, Nicholas M. Bernthal, Lara E. Davis, Jacqueline Vuky, Christopher Tait, Bahar Matin, Supraja Narasimhan, Maitreyi G. Sharma, Rodrigo Ruiz‐Soto, Matthew L. Sherman, William D. Tap

    Izdano 2024
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

    Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial od Michael C. Heinrich, Robin L. Jones, Suzanne George, Hans Gelderblom, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Brittany L. Siontis, David Goldstein, Kjetil Boye, César Sánchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, César Serrano, Neeta Somaiah, Ping Chi, William M. Reichmann, Kam Sprott, Haroun Achour, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Jean‐Yves Blay, Sebastian Bauer

    Izdano 2024
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes od Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti, Guillermo Garcia‐Manero, Rena Buckstein, Valeria Santini, María Díez‐Campelo, Carlo Finelli, Mario Cazzola, Osman İlhan, Mikkael A. Sekeres, José Falantes, Beatriz Arrizabalaga, Flavia Salvi, Valentina Giai, Paresh Vyas, David Bowen, Dominik Selleslag, Amy E. DeZern, Joseph G. Jurcic, Ulrich Germing, Katharina S. Götze, Bruno Quesnel, Odile Beyne‐Rauzy, Thomas Cluzeau, Maria-Teresa Voso, Dominiek Mazure, Edo Vellenga, Peter L. Greenberg, Eva Hellström-Lindberg, Amer M. Zeidan, Lionel Adès, Amit Verma, Michael R. Savona, Abderrahmane Laadem, Aziz Benzohra, Jennie Zhang, Anita Rampersad, Diana Dunshee, Peter G. Linde, Matthew L. Sherman, Rami S. Komrokji, Alan F. List

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

    A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia od Maria Domenica Cappellini, Vip Viprakasit, Alì Taher, Pencho Georgiev, Kevin H.M. Kuo, Thomas D. Coates, Ersi Voskaridou, Hong-Keng Liew, Idit Pazgal-Kobrowski, Gian Luca Forni, Silverio Perrotta, Abderrahim Khélif, Ashutosh Lal, Antonis Kattamis, Efthymia Vlachaki, Raffaella Origa, Yeşim Aydınok, Mohamed Béjaoui, P. Joy Ho, Lee-Ping Chew, Ping Chong Bee, Soo-min Lim, Meng‐Yao Lu, Adisak Tantiworawit, Penka Ganeva, Liana Gercheva, Farrukh Shah, Ellis J. Neufeld, Alexis A. Thompson, Abderrahmane Laadem, Jeevan K. Shetty, Jun Zou, Jennie Zhang, Dimana Miteva, Tatiana Zinger, Peter G. Linde, Matthew L. Sherman, Olivier Hermine, John B. Porter, Antonio Piga

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: